United States · 
Who invested in GentiBio?
GentiBio's investors include OrbiMed, RA Capital Management and Novartis.
United States · Series A startup
Who invested in GentiBio
Funding summaryUpdated 26 Oct 2026
$157Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $157MAug 2021
- Investors
- 3
The rounds
- Aug 2021
Founders and team
From GentiBio's own website: 1 on the team.
- Nathan ZammitPrincipal Scientist
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists GentiBio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about GentiBio
How much has GentiBio raised?
GentiBio has raised $157M across 1 round since 2021.
When did GentiBio last raise?
GentiBio's most recent round was a Series A of $157M in Aug 2021.
What was GentiBio's biggest round?
Its most recent round, $157M in Aug 2021, is also its largest on record.
Who backed GentiBio first?
GentiBio's first round on record, in Aug 2021, was backed by OrbiMed, RA Capital Management and Novartis.
What stage is GentiBio at?
GentiBio's latest named round is a Series A, in Aug 2021.
Where is GentiBio based?
GentiBio is based in the United States.
Companies like GentiBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.